This morning investors are almost certainly expected to take a closer look at the GeoVax (NASDAQ:GOVX) stock after it emerged as one of the notable gainers and ended the day with gains of as much as 67%.
Trading Data
On Monday, GOVX stock surged 67% to 2.32 with 166.09 million shares, compared to its average volume of 1.60 million shares. The stock moved within a range of $1.6500 – 2.8500 after opening trade at $1.99.
Key Buzz
There was no news about the company or any announcement but it seems that eagle-eyed investors had found something in the company’s pipeline of products that created a wave of optimism. In a press release back in 2020, the company’s Chief Executive Officer had noted that the vaccine vector it had in the works had already been approved for preventing monkeypox.
Considering the fact that the latest outbreak of monkeypox has come as a source of intense panic among populations and governments, the quote from 2020 has made GeoVax one of the companies which could potentially be important if the outbreak spreads.
It ought to be noted that President of the United States Joe Biden recently noted that the monkeypox is something that should be a source of concern for everybody. At this point in time, it may be a good idea for investors to add the stock to their watch lists and keep an eye on developments.
Technical Data
GOVX stock is trading above the 20-Day and 50-Day Moving averages of $0.97 and $1.06 respectively. However, the stock is trading below the 200-Day moving average of $3.
